Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Azenta Inc (AZTA)

Azenta Inc (AZTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,257,576
  • Shares Outstanding, K 45,780
  • Annual Sales, $ 656,320 K
  • Annual Income, $ -164,170 K
  • EBIT $ -55 M
  • EBITDA $ 146 M
  • 60-Month Beta 1.64
  • Price/Sales 1.86
  • Price/Cash Flow 5.87
  • Price/Book 0.72

Options Overview Details

View History
  • Implied Volatility 56.66% ( -10.21%)
  • Historical Volatility 73.21%
  • IV Percentile 73%
  • IV Rank 45.12%
  • IV High 87.94% on 04/14/25
  • IV Low 30.94% on 08/30/24
  • Put/Call Vol Ratio 3.50
  • Today's Volume 9
  • Volume Avg (30-Day) 293
  • Put/Call OI Ratio 4.64
  • Today's Open Interest 6,285
  • Open Int (30-Day) 3,657

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/25
See More
  • Average Estimate 0.13
  • Number of Estimates 2
  • High Estimate 0.15
  • Low Estimate 0.10
  • Prior Year 0.16
  • Growth Rate Est. (year over year) -18.75%

Price Performance

See More
Period Period Low Period High Performance
1-Month
23.91 +14.89%
on 05/07/25
29.08 -5.54%
on 05/12/25
+1.97 (+7.73%)
since 04/16/25
3-Month
23.91 +14.89%
on 05/07/25
47.55 -42.23%
on 02/26/25
-17.94 (-39.51%)
since 02/14/25
52-Week
23.91 +14.89%
on 05/07/25
63.58 -56.79%
on 07/31/24
-23.87 (-46.49%)
since 05/16/24

Most Recent Stories

More News
2 Cash-Heavy Stocks Worth Your Attention and 1 to Approach with Caution

2 Cash-Heavy Stocks Worth Your Attention and 1 to Approach with Caution

AZTA : 27.47 (+2.85%)
GHM : 37.29 (+1.06%)
WBTN : 8.97 (+1.01%)
2 Cash-Heavy Stocks Worth Your Attention and 1 to Approach with Caution

2 Cash-Heavy Stocks Worth Your Attention and 1 to Approach with Caution

AZTA : 27.47 (+2.85%)
GHM : 37.29 (+1.06%)
WBTN : 8.97 (+1.01%)
3 Cash-Producing Stocks Facing Headwinds

3 Cash-Producing Stocks Facing Headwinds

AZTA : 27.47 (+2.85%)
FTV : 73.19 (+0.98%)
XRAY : 16.70 (+1.21%)
3 of Wall Street’s Favorite Stocks in the Doghouse

3 of Wall Street’s Favorite Stocks in the Doghouse

MTW : 11.76 (+2.08%)
TDS : 34.93 (+1.54%)
AZTA : 27.47 (+2.85%)
3 Reasons AZTA is Risky and 1 Stock to Buy Instead

3 Reasons AZTA is Risky and 1 Stock to Buy Instead

NOW : 1,040.18 (+0.48%)
AZTA : 27.47 (+2.85%)
Winners And Losers Of Q4: IQVIA (NYSE:IQV) Vs The Rest Of The Drug Development Inputs & Services Stocks

Winners And Losers Of Q4: IQVIA (NYSE:IQV) Vs The Rest Of The Drug Development Inputs & Services Stocks

FTRE : 4.44 (-6.53%)
UFPT : 253.30 (+3.95%)
AZTA : 27.47 (+2.85%)
RGEN : 126.50 (+2.63%)
IQV : 142.82 (+1.70%)
Unpacking Q4 Earnings: West Pharmaceutical Services (NYSE:WST) In The Context Of Other Drug Development Inputs & Services Stocks

Unpacking Q4 Earnings: West Pharmaceutical Services (NYSE:WST) In The Context Of Other Drug Development Inputs & Services Stocks

FTRE : 4.44 (-6.53%)
UFPT : 253.30 (+3.95%)
AZTA : 27.47 (+2.85%)
WST : 216.64 (+2.83%)
IQV : 142.82 (+1.70%)
Drug Development Inputs & Services Stocks Q4 In Review: Medpace (NASDAQ:MEDP) Vs Peers

Drug Development Inputs & Services Stocks Q4 In Review: Medpace (NASDAQ:MEDP) Vs Peers

MEDP : 305.66 (+3.12%)
FTRE : 4.44 (-6.53%)
AZTA : 27.47 (+2.85%)
RGEN : 126.50 (+2.63%)
CRL : 140.97 (+1.50%)
Drug Development Inputs & Services Stocks Q4 Results: Benchmarking Fortrea (NASDAQ:FTRE)

Drug Development Inputs & Services Stocks Q4 Results: Benchmarking Fortrea (NASDAQ:FTRE)

FTRE : 4.44 (-6.53%)
MEDP : 305.66 (+3.12%)
AZTA : 27.47 (+2.85%)
WST : 216.64 (+2.83%)
IQV : 142.82 (+1.70%)
Unpacking Q4 Earnings: UFP Technologies (NASDAQ:UFPT) In The Context Of Other Drug Development Inputs & Services Stocks

Unpacking Q4 Earnings: UFP Technologies (NASDAQ:UFPT) In The Context Of Other Drug Development Inputs & Services Stocks

FTRE : 4.44 (-6.53%)
UFPT : 253.30 (+3.95%)
AZTA : 27.47 (+2.85%)
WST : 216.64 (+2.83%)
CRL : 140.97 (+1.50%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Azenta Inc. is a provider of life sciences solutions. The company provides reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and advanced cell therapies for the pharmaceutical, biotech, academic and healthcare institutions. Azenta...

See More

Key Turning Points

3rd Resistance Point 29.10
2nd Resistance Point 28.38
1st Resistance Point 27.92
Last Price 27.47
1st Support Level 26.74
2nd Support Level 26.02
3rd Support Level 25.56

See More

52-Week High 63.58
Fibonacci 61.8% 48.43
Fibonacci 50% 43.75
Fibonacci 38.2% 39.06
Last Price 27.47
52-Week Low 23.91

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar